We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $79.5B
1-Year Est. Return 27.1%
This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.21%
AUM
$41.6B
AUM Growth
+$2.78B
Cap. Flow
+$1.7B
Cap. Flow %
4.09%
Top 10 Hldgs %
16.13%
Holding
3,882
New
219
Increased
1,735
Reduced
1,600
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 9.27%
2 Financials 5.67%
3 Healthcare 5.44%
4 Consumer Discretionary 3.73%
5 Industrials 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRFS
3601
DELISTED
BRF SA
BRFS
$18K ﹤0.01%
11,780
-95,270
-89% -$198K
MBIO icon
3602
Mustang Bio
MBIO
$4.5M
$18K ﹤0.01%
64
+20
+45% +$6.83K
PXLW icon
3603
Pixelworks
PXLW
$37.4M
$18K ﹤0.01%
892
SCOR icon
3604
Comscore
SCOR
$112M
$18K ﹤0.01%
798
CTOS.WS
3605
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
$18K ﹤0.01%
46,500
AUR icon
3606
Aurora
AUR
$12.2B
$17K ﹤0.01%
14,437
+2,000
+16% +$3.41K
GLDG
3607
GoldMining Inc
GLDG
$185M
$17K ﹤0.01%
15,832
-2,200
-12% -$2.31K
IGC icon
3608
IGC Pharma
IGC
$26M
$17K ﹤0.01%
53,806
-150
-0.3% -$61
OTLK icon
3609
Outlook Therapeutics
OTLK
$194M
$17K ﹤0.01%
826
FRZA
3610
DELISTED
Forza X1, Inc. Common Stock
FRZA
$17K ﹤0.01%
+14,000
New +$23.4K
LIAN
3611
DELISTED
LianBio American Depositary Shares
LIAN
$17K ﹤0.01%
10,830
JNCE
3612
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$17K ﹤0.01%
+15,572
New +$22.2K
VFF icon
3613
Village Farms International
VFF
$242M
$16K ﹤0.01%
12,635
+145
+1% +$276
BIOR
3614
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$16K ﹤0.01%
508
-12
-2% -$875
NAK
3615
Northern Dynasty Minerals
NAK
$779M
$15K ﹤0.01%
70,306
+37,400
+114% +$9.04K
VBIV
3616
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$15K ﹤0.01%
1,293
-32
-2% -$564
KEEL
3617
Keel Infrastructure Corp
KEEL
$2.45B
$14K ﹤0.01%
31,961
-4,227
-12% -$3.11K
MTNB icon
3618
Matinas BioPharma
MTNB
$2.03M
$14K ﹤0.01%
585
NCNA
3619
NuCana
NCNA
$5.24M
$14K ﹤0.01%
4
RCAT icon
3620
Red Cat Holdings
RCAT
$1.12B
$14K ﹤0.01%
+15,577
New +$19.3K
TNXP icon
3621
Tonix Pharmaceuticals
TNXP
$161M
$14K ﹤0.01%
+2
New +$17.3K
VXRT
3622
DELISTED
Vaxart
VXRT
$14K ﹤0.01%
14,690
+215
+1% +$304
SIDU icon
3623
Sidus Space
SIDU
$179M
$13K ﹤0.01%
120
+10
+9% +$1.69K
SOBR icon
3624
SOBR Safe
SOBR
$1.61M
$13K ﹤0.01%
+13
New +$27.4K
TRML
3625
DELISTED
Tourmaline Bio
TRML
$13K ﹤0.01%
1,300

Similar funds

Commonwealth Equity Services's Q4 2022 Portfolio in Review

As of Q4 2022, Commonwealth Equity Services held 3,882 positions worth $41.6B, up 7.2% from $38.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Commonwealth Equity Services deployed $1.7B of net new capital in Q4 2022, opening 219 new positions and adding to 1,735 existing holdings. Its largest new stake was FS Credit Opportunities Corp: 5,433,129 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $30.9M trimmed.

  • Commonwealth Equity Services's largest Q4 2022 buy was FS Credit Opportunities Corp: 5,433,129 shares worth $25.6M.
  • Commonwealth Equity Services added most to iShares Core US Aggregate Bond ETF in Q4 2022, an estimated $50.6M increase.
  • Commonwealth Equity Services's biggest Q4 2022 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $30.9M.
  • Commonwealth Equity Services fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $15.2M.
  • Commonwealth Equity Services's ten largest holdings make up 16% of its $41.6B portfolio in Q4 2022.
  • Commonwealth Equity Services opened 219 new positions and closed 179 in Q4 2022.
  • Commonwealth Equity Services's portfolio value rose 7.2% quarter-over-quarter to $41.6B.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.